Teva Pharmaceutical Industries Ltd logo

TEVA

Teva Pharmaceutical Industries Ltd

$17.01

Earnings Summary

Revenue
$3832Mn
Net Profits
$-139Mn
Net Profit Margins
-3.63%

Highlights

Revenue:

Teva Pharmaceutical Industries Ltd’s revenue jumped 4.67% since last year same period to $3832Mn in the Q1 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated -14.02% fall in its revenue since last 3-months.

Net Profits:

Teva Pharmaceutical Industries Ltd’s net profit jumped 32.2% since last year same period to $-139Mn in the Q1 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated -132.4% fall in its net profits since last 3-months.

Net Profit Margins:

Teva Pharmaceutical Industries Ltd’s net profit margin jumped 35.22% since last year same period to -3.63% in the Q1 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated -137.69% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Teva Pharmaceutical Industries Ltd post its latest quarter earnings

EPS Estimate Current Quarter
0.56
EPS Estimate Current Year
0.56

Highlights

EPS Estimate Current Quarter:

Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current quarter stand at 0.56 - a 9.8% jump from last quarter’s estimates.

EPS Estimate Current Year:

Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current year stand at 0.56.

Key Ratios

Key ratios of the Teva Pharmaceutical Industries Ltd post its Q1 2024 earnings

Earning Per Share (EPS)
0.48
Return on Assets (ROA)
0.05
Return on Equity (ROE)
-0.1

Highlights

Earning Per Share (EPS):

Teva Pharmaceutical Industries Ltd’s earning per share (EPS) jumped 20% since last year same period to 0.48 in the Q1 2024. This indicates that the Teva Pharmaceutical Industries Ltd has generated 20% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Teva Pharmaceutical Industries Ltd’s return on assets (ROA) stands at 0.05.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Teva Pharmaceutical Industries Ltd’s return on equity (ROE) stands at -0.1.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-08
0.51
0.48
-5.88%